胰島素貼片幫浦市場規模、佔有率和成長分析：按類型、胰島素類型、技術、應用、最終用戶、通路和地區分類－2026-2033年產業預測

2024 年全球胰島素貼片幫浦市場價值為 15.2 億美元，預計到 2025 年將成長至 17.1 億美元，到 2033 年將成長至 45.2 億美元，在預測期（2026-2033 年）內複合年成長率為 12.82%。

胰島素貼片幫浦市場正受到胰島素依賴型糖尿病盛行率不斷上升以及患者對隱藏、易用治療方法的需求的顯著推動，這些方案旨在提高用藥依從性和整體生活品質。這些創新的無導管裝置能夠持續輸注胰島素，同時簡化給藥方式。在微流體進步和法規核准的支持下，市場正從笨重的外置泵轉向精密的貼片系統，從而擴大了應用範圍並帶來了更多投資機會。影響市場成長的關鍵因素是與持續血糖監測儀 (CGM) 和醫療平台的互通性。這實現了無縫數據交換，支援自動胰島素劑量調整和臨床監測。貼片幫浦、CGM 和演算法控制設備的結合正在改善患者的治療效果，這進一步加速了保險公司的接受度，並擴大了患者的用藥範圍。

全球胰島素貼片幫浦幫浦市場的成長要素

受胰島素治療需求患者數量不斷成長的推動，全球胰島素貼片幫浦市場正經歷顯著成長。隨著患者和醫護人員尋求更便利、更非侵入性的給藥方式以提高治療依從性和管理效果，胰島素貼片幫浦正日益普及。其緊湊、無導管的設計不僅簡化了日常操作，還減少了因顯眼的胰島素輸注裝置而帶來的社會偏見，從而促進了不同患者群體的接受度。為此，製造商正致力於開發使用者友善產品，並進行宣傳宣傳活動以推廣這些創新技術，從而提高臨床接受度，並改善患者的生活品質。

全球胰島素貼片幫浦市場的限制因素

胰島素貼片幫浦幫浦的高昂成本（包括初始購置成本和持續的耗材費用）對許多患者和醫療系統而言構成重大的經濟障礙，阻礙了其快速普及。此外，報銷機制不完善和保險覆蓋範圍不一致加劇了這些經濟挑戰，迫使潛在用戶選擇更傳統、更經濟的替代方案。這些經濟限制可能會延遲醫療機構的採購決策，可能將市場成長局限於富裕人群和資源豐富的醫療機構。因此，製造商拓展分銷網路和提高胰島素貼片幫浦技術普及率的能力受到限制。

全球胰島素貼片幫浦市場趨勢

全球胰島素貼片幫浦市場正呈現出顯著的連網糖尿病管理趨勢，這主要得益於這些設備與消費者和臨床數位生態系統的融合。隨著貼片幫浦與行動應用程式、雲端運算和遠端醫療服務的互通性不斷增強，數據流得以無縫銜接，從而實現遠端劑量調整、個人化提醒和協調的治療路徑。這項進步不僅提高了患者的參與度，也簡化了臨床醫師的工作流程。醫療設備製造商、軟體開發商和醫療網路之間的策略合作豐富了服務內容，而對安全資料交換和使用者友善介面的高度重視則提高了市場接受度，並有助於培養病患的長期忠誠度。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球胰島素貼片幫浦市場規模：按類型分類

• 繫繩式貼片幫浦
• 無內胎貼片幫浦

全球胰島素貼片幫浦市場規模：以胰島素類型分類

• 速效胰島素
• 長效胰島素

全球胰島素貼片幫浦市場規模：依技術分類

• 閉合迴路（人工胰臟）
• 開放回路型

全球胰島素貼片幫浦市場規模：按應用領域分類

• 1型糖尿病
• 2型糖尿病

全球胰島素貼片幫浦市場規模：依最終用戶分類

• 醫院
• 居家照護
• 門診糖尿病中心

全球胰島素貼片幫浦市場規模：按通路分類

• 直接的
• 藥局
• 線上

全球胰島素貼片幫浦市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Insulet Corporation（Omnipod）
• Medtronic（MiniMed）
• Tandem Diabetes Care
• Becton Dickinson
• CeQur Corporation（PaQ）
• Roche（Accu-Chek Solo）
• Ypsomed AG（mylife YpsoPump）
• Enable Injections
• Sensile Medical（Gerresheimer）
• PHC Holdings（Phchd）
• Sooil Development（Dana）
• Debiotech SA
• Microport Scientific
• Kaleido Biosciences
• Diabeloop SA
• Beta Bionics
• Bigfoot Biomedical
• Dexcom（CGM integration）
• Abbott Diabetes Care
• Novo Nordisk

結論與建議

Global Insulin Patch Pumps Market size was valued at USD 1.52 Billion in 2024 and is poised to grow from USD 1.71 Billion in 2025 to USD 4.52 Billion by 2033, growing at a CAGR of 12.82% during the forecast period (2026-2033).

The insulin patch pumps market is significantly driven by the increasing incidence of insulin-dependent diabetes and patient preferences for discreet, user-friendly treatment options that enhance adherence and overall quality of life. These innovative, tubeless devices facilitate continuous insulin delivery while simplifying dosing. The market has transitioned from bulky external pumps to sleek adhesive patch systems, fueled by technological advancements in microfluidics and regulatory approvals, leading to greater adoption and investment opportunities. A vital factor influencing market growth is the interoperability with continuous glucose monitors and health platforms, which allows for seamless data exchange that supports automated insulin adjustments and clinical supervision. The combination of patch pumps with CGMs and algorithmic controllers has been linked to improved patient outcomes, further driving payer acceptance and broadening patient access.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insulin Patch Pumps market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insulin Patch Pumps Market Segments Analysis

Global insulin patch pumps market is segmented by type, insulin type, technology, application, end-user, distribution and region. Based on type, the market is segmented into Tethered Patch Pumps and Tubeless Patch Pumps. Based on insulin type, the market is segmented into Rapid-Acting Insulin and Long-Acting Insulin. Based on technology, the market is segmented into Closed-Loop (Artificial Pancreas) and Open-Loop. Based on application, the market is segmented into Type 1 Diabetes and Type 2 Diabetes. Based on end-user, the market is segmented into Hospitals, Home Care and Ambulatory Diabetes Centers. Based on distribution, the market is segmented into Direct, Pharmacies and Online. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insulin Patch Pumps Market

The global market for insulin patch pumps is experiencing significant growth driven by the rising prevalence of individuals requiring insulin therapy. As patients and healthcare providers look for less invasive and more convenient delivery methods to enhance treatment adherence and management, insulin patch pumps are becoming increasingly popular. Their compact and tubeless design not only simplifies daily routines but also alleviates any stigma linked to more visible insulin delivery devices, thereby encouraging wider adoption among various patient populations. In response, manufacturers are focusing on developing user-friendly products and launching awareness campaigns to promote these innovations, which leads to greater acceptance in clinical environments and improved patient quality of life.

Restraints in the Global Insulin Patch Pumps Market

The high expenses linked to insulin patch pumps, encompassing both the initial purchase and ongoing consumable costs, present a significant financial hurdle for numerous patients and healthcare systems, hindering swift adoption. Additionally, insufficient reimbursement frameworks and inconsistencies in insurance coverage amplify these affordability issues, compelling potential users to opt for conventional, more cost-effective alternatives. These economic limitations may delay procurement choices made by healthcare providers and confine market growth primarily to affluent demographics or well-resourced healthcare environments. Consequently, this restricts manufacturers' ability to expand distribution and attain broader utilization of insulin patch pump technology.

Market Trends of the Global Insulin Patch Pumps Market

The Global Insulin Patch Pumps market is witnessing a notable trend towards connected diabetes management, driven by the integration of these devices with consumer and clinical digital ecosystems. As patch pumps enhance their interoperability with mobile applications, cloud computing, and telehealth services, they enable a seamless flow of data that facilitates remote titration, personalized reminders, and coordinated care pathways. This advancement is not only improving patient engagement but also streamlining clinician workflows. Strategic partnerships among device manufacturers, software developers, and healthcare networks are enriching service offerings, while a strong emphasis on secure data exchange and user-friendly interfaces enhances market acceptance and fosters long-term patient loyalty.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Insulin Patch Pumps Market Size by Type & CAGR (2026-2033)

• Market Overview
• Tethered Patch Pumps
• Tubeless Patch Pumps

Global Insulin Patch Pumps Market Size by Insulin Type & CAGR (2026-2033)

• Market Overview
• Rapid-Acting Insulin
• Long-Acting Insulin

Global Insulin Patch Pumps Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Closed-Loop (Artificial Pancreas)
• Open-Loop

Global Insulin Patch Pumps Market Size by Application & CAGR (2026-2033)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes

Global Insulin Patch Pumps Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Home Care
• Ambulatory Diabetes Centers

Global Insulin Patch Pumps Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Direct
• Pharmacies
• Online

Global Insulin Patch Pumps Market Size & CAGR (2026-2033)

• North America (Type, Insulin Type, Technology, Application, End-User, Distribution)
  • US
  • Canada
• Europe (Type, Insulin Type, Technology, Application, End-User, Distribution)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Insulin Type, Technology, Application, End-User, Distribution)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Insulin Type, Technology, Application, End-User, Distribution)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Insulin Type, Technology, Application, End-User, Distribution)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Insulet Corporation (Omnipod)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (MiniMed)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CeQur Corporation (PaQ)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Accu-Chek Solo)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AG (mylife YpsoPump)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Enable Injections
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sensile Medical (Gerresheimer)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PHC Holdings (Phchd)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sooil Development (Dana)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Debiotech SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microport Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaleido Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diabeloop SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beta Bionics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bigfoot Biomedical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom (CGM integration)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Diabetes Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations